Mainz Biomed B.V.
MYNZNASDAQHealthcare
$3.59
+$0.03(+0.84%)
Market Cap$14691084
P/E Ratio—
52W High$5.34
52W Low$0.5476
Mainz Biomed B.V. (MYNZ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MYNZ · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.54M | $0.89M | $0.90M | $0.53M | $0.58M |
| Cost of Revenue | $0.76M | $0.32M | $0.39M | $0.35M | $0.40M |
| Gross Profit | ($0.23M) | $0.57M | $0.51M | $0.18M | $0.18M |
| Gross Margin %(computed) | -42.07% | 64.31% | 56.91% | 34.38% | 30.77% |
| Operating Expenses | |||||
| R&D Expenses | $4.91M | $5.84M | $9.59M | $3.66M | $0.47M |
| G&A Expenses | $5.11M | $8.08M | $13.42M | $17.83M | $8.45M |
| Total Operating Expenses | $13.27M | $19.27M | $27.15M | $26.36M | $9.56M |
| Operating Income | ($13.50M) | ($18.70M) | ($26.64M) | ($26.44M) | ($9.72M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | ($0.37M) | $1.08M | $0.81M | $0.29M | $0.34M |
| Income Before Tax | ($16.21M) | ($21.65M) | ($26.30M) | ($26.39M) | ($11.70M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.38M |
| Net Income | ($16.21M) | ($21.65M) | ($26.30M) | ($26.45M) | ($11.69M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.70 | $-22.36 | $-1.62 | $-1.87 | $-1.67 |
| Wtd Avg Shares | 6.00M | 0.97M | 16.24M | 14.16M | 7.21M |
| EBITDA | ($12.88M) | ($19.56M) | ($25.01M) | ($25.72M) | ($11.28M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Mainz Biomed B.V. data
About Mainz Biomed B.V. (MYNZ) Income Statement
Mainz Biomed B.V. (MYNZ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MYNZ reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -42.07%), and net income of ($0.02B) — a net profit margin of -3018.31%.
Frequently asked questions
MYNZ · 4 questionsMainz Biomed B.V. (MYNZ) reported revenue of $0.00B for 2025, down 39.9% year-over-year.
MYNZ revenueMYNZ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08